| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1191/0961203303LU503OA |
| P698 | PubMed publication ID | 14714912 |
| P50 | author | Angela Tincani | Q73304219 |
| Pier Luigi Meroni | Q38544871 | ||
| P2093 | author name string | S Pellegrini | |
| A Salmaggi | |||
| E Raschi | |||
| E Corsini | |||
| C Testoni | |||
| I Cavazzana | |||
| N Sepp | |||
| P2860 | cites work | Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 |
| Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies | Q48259097 | ||
| Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients | Q48290639 | ||
| Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1. | Q48355306 | ||
| Selective expression of adhesion molecules on human brain microvascular endothelial cells | Q48697836 | ||
| Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries | Q48793169 | ||
| Astrocytes induce blood–brain barrier properties in endothelial cells | Q57318253 | ||
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis | Q28216915 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen | Q30943894 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Vascular-bed--specific hemostasis and hypercoagulable states | Q33637363 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Complement-endothelial cell interactions: pathophysiological implications. | Q33686076 | ||
| Experimental thrombosis and antiphospholipid antibodies: new insights | Q34021315 | ||
| Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications | Q34315026 | ||
| Pathogenic mechanisms mediating antiphospholipid syndrome | Q34404108 | ||
| The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation | Q34669832 | ||
| The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation | Q34669837 | ||
| CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. | Q34736484 | ||
| Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta | Q36212607 | ||
| Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus | Q39556249 | ||
| beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program | Q40693493 | ||
| Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal | Q40725670 | ||
| Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells | Q40997117 | ||
| Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody | Q41209908 | ||
| Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
| B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines. | Q42486013 | ||
| Exogenous tat protein activates central nervous system-derived endothelial cells | Q44367861 | ||
| Co-distribution of protease nexin-1 and protease nexin-2 in brains of non-human primates | Q46444454 | ||
| Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. | Q48176770 | ||
| P433 | issue | 12 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 919-928 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Endothelium and the brain in CNS lupus | |
| P478 | volume | 12 |
| Q44106531 | Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo |
| Q33251075 | Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus |
| Q34896821 | Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus |
| Q35849691 | Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome |
| Q34787911 | Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. |
| Q24805595 | Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q39946264 | Colour Doppler ultrasound of the ocular circulation in patients with systemic lupus erythematosus identifies altered microcirculatory haemodynamics |
| Q37205229 | Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus |
| Q35555433 | Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus |
| Q43164302 | Cranial nerve palsies: sarcoidosis to systemic lupus erythematosus |
| Q33356831 | Endothelium activation in the anti-phospholipid syndrome |
| Q40344419 | Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus |
| Q37440005 | Losing your nerves? Maybe it's the antibodies |
| Q36707992 | Neuroimmunopathology in a murine model of neuropsychiatric lupus |
| Q37154879 | Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons |
| Q34075832 | Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience |
| Q52085774 | Neuropsychological development of children born to patients with systemic lupus erythematosus. |
| Q37556128 | Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers |
| Q36666808 | Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. |
| Q33292539 | Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? |
| Q36458150 | Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). |
| Q38844621 | Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment |
| Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
| Q37283036 | Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome |
| Q36908457 | Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus |
Search more.